OSR Competitors

Stocks . USA . 
Stock . OSR Holdings
OSRH Stock   0.62  0.03  4.62%   
OSR Holdings competes with Adlai Nortye, GeoVax Labs, Lipocine, BioLineRx, and Edesa Biotech; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing OSR Holdings competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of OSR Holdings to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out OSR Holdings Correlation with its peers.
For more detail on how to invest in OSR Stock please use our How to Invest in OSR Holdings guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of OSR Holdings competition on your existing holdings.
  
Build AI portfolio with OSR Stock
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.030.569.46
Details
Intrinsic
Valuation
LowRealHigh
0.030.519.41
Details
Naive
Forecast
LowNextHigh
0.010.509.40
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.480.620.76
Details

OSR Holdings Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between OSR Holdings and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of OSR and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of OSR Holdings does not affect the price movement of the other competitor.

High positive correlations

EDSA
+ 0.83
BLRX
PMN
+ 0.82
BLRX
BLRX
+ 0.79
GOVX
PMN
+ 0.74
EDSA
PMN
+ 0.72
GOVX
EDSA
+ 0.69
GOVX
  

High negative correlations

LPCN
- 0.73
GOVX
THAR
- 0.59
LPCN
PMN
- 0.53
ADAP
EDSA
- 0.44
ADAP
APLM
- 0.39
ERNA
BLRX
- 0.39
LPCN

Risk-Adjusted Indicators

There is a big difference between OSR Stock performing well and OSR Holdings Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze OSR Holdings' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ANL  4.17 (0.13) 0.00 (0.07) 0.00 
 0.00 
 9.09 
(8.48)
 31.06 
ADAP  12.67 (1.39) 0.00  1.87  0.00 
 0.00 
 49.18 
(18.18)
 120.50 
GOVX  5.09 (1.76) 0.00 (0.59) 0.00 
 0.00 
 8.11 
(13.16)
 48.23 
LPCN  3.17  0.97  0.28 (1.21) 2.26 
(3.88)
 12.67 
(4.48)
 18.81 
BLRX  2.82 (0.39) 0.00 (0.30) 0.00 
 0.00 
 5.21 
(5.31)
 13.04 
EDSA  3.17 (0.88) 0.00 (1.74) 0.00 
 0.00 
 5.20 
(6.91)
 30.37 
THAR  4.60 (0.02) 0.00  0.09  0.00 
 0.00 
 8.89 
(9.64)
 35.56 
ERNA  4.77  0.29  0.07  0.25  4.65 
(5.66)
 13.33 
(7.41)
 51.97 
APLM  7.89  0.78  0.05 (0.24) 9.08 
(11.41)
 17.50 
(17.72)
 96.36 
PMN  4.47 (0.26) 0.00 (0.09) 0.00 
 0.00 
 10.00 
(9.37)
 38.10 
All Fundamental Data

OSR Holdings Competitive Analysis

The better you understand OSR Holdings competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, OSR Holdings' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across OSR Holdings' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
OSRH ANL ADAP GOVX LPCN BLRX EDSA THAR ERNA APLM
 4.62 
 0.62 
OSR
 0.65 
 1.52 
Adlai
 6.49 
 0.04 
Adaptimmune
 11.76 
 0.19 
GeoVax
 8.22 
 4.61 
Lipocine
 4.17 
 3.00 
BioLineRx
 4.79 
 1.39 
Edesa
 1.61 
 2.45 
Tharimmune
 3.13 
 1.24 
Eterna
 6.81 
 17.23 
Apollomics
Market Volatility
(90 Days Market Risk)
Out of control
Very risky
Out of control
Dangerous
Relatively risky
Somewhat reliable
Risky
Very risky
Abnormally volatile
Risky
Market Performance
(90 Days Performance)
Weak
Weakest
Weakest
Weakest
Solid
Weakest
Weakest
Weakest
Soft
Soft
Odds of Financial Distress
(Probability Of Bankruptcy)
Risky
Risky
Hazard
Fair
Tiny
Risky
Strong
Risky
Risky
Risky
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Over Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Sell
Not Rated
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
N/A
N/A
4.0
9.51
22.23
4.58
2.68
N/A
3.08
N/A
Net Asset
2.3 M
71.27 M
245.96 M
8.16 M
22.51 M
38.91 M
13.53 M
3.72 M
5.27 M
13.1 M
Profit Margin
N/A
N/A
-2.61
N/A
-1.27
-0.45
N/A
N/A
N/A
N/A
EBITDA
(2.07 M)
(48.08 M)
(52.66 M)
(24.88 M)
(1.11 M)
3.92 M
(7.07 M)
(12.43 M)
(36.12 M)
(41.05 M)
Operating Margin
-6.06
-12.21
-2.21
-7.62
-29.34
-7.58
N/A
N/A
N/A
10.07
Current Valuation
18.09 M
22.77 M
31.98 M
3.33 M
10.46 M
(812 K)
11.15 M
79.81 M
7.55 M
30.83 M
Price To Book
0.19
2.22
2.68
0.97
1.81
0.64
3.81
14.18
2.82
8.15
Retained Earnings
(8.33 M)
(429.32 M)
(1.09 B)
(129.36 T)
(199.77 M)
(399.83 M)
(65.91 M)
(36.9 M)
(231.54 M)
(700.82 M)
Current Asset
N/A
N/A
199.54 M
1.24 M
29.41 M
48.18 M
6.92 M
N/A
N/A
N/A
Beta
1.34
-0.89
2.49
3.64
1.03
0.58
0.08
1.45
6.72
1.81
Number Of Employees
19
123
506
17
16
28
17
2
6
13
Shares Outstanding
25.67 M
31.24 M
265.05 M
30.06 M
5.55 M
4.26 M
8.33 M
35.04 M
7.85 M
2.14 M
Cash Flow From Operations
(2.19 M)
(51.82 M)
(73.21 M)
(24.68 M)
(1.22 M)
(43.87 M)
(7.32 M)
(10.9 M)
(15.84 M)
(28.74 M)
Total Debt
2.56 M
27.23 M
74.21 M
3.11 M
438.62 K
15.04 M
1.21 M
2.41 M
684 K
966 K
Return On Equity
-0.0895
-1.03
-13.41
-3.77
-0.33
-0.46
-1.0
-2.25
-22.64
-2.34
Return On Asset
-0.018
-0.33
-0.41
-1.79
-0.21
-0.15
-0.57
-1.0
-0.89
-0.75
Number Of Shares Shorted
1.18 M
8.52 K
31.38 M
3.03 M
115.27 K
180.53 K
51.06 K
661.84 K
127.9 K
17.04 K
Book Value Per Share
3.46
0.69
-0.27
0.17
2.61
0.008
0.45
0.85
0.46
4.41
Current Liabilities
N/A
N/A
22.66 M
126.99 K
1.57 M
3.14 M
581.49 K
N/A
N/A
N/A
Total Asset
2.3 M
71.27 M
245.96 M
8.16 M
22.51 M
38.91 M
13.53 M
3.72 M
5.27 M
13.1 M
Short Ratio
0.11
0.08
0.19
5.52
2.21
6.15
0.06
0.22
0.01
0.28
Target Price
10.0
9.0
0.68
9.63
6.88
26.0
11.0
5.0
3.0
2.0
Debt To Equity
N/A
2.44
0.2
0.009
0.005
0.046
0.003
N/A
0.19
N/A
Shares Owned By Institutions
0.87
0.19
31.23
11.5
9.58
1.07
34.51
3.19
6.58
0.67
Market Capitalization
15.89 M
55.72 M
14.55 M
5.18 M
25.59 M
15.18 M
12.17 M
87.26 M
10.05 M
44.92 M
Price To Earning
N/A
12.24
-7.73
-1.25
15.8
-3.88
-3.96
N/A
N/A
N/A
Price To Earnings To Growth
N/A
N/A
0.11
N/A
N/A
0.2
N/A
N/A
-0.03
N/A
Price To Sales
13.89
29.1
0.22
1.54
5.92
1.06
120478.0
N/A
10046.58
200.15
Net Income
(2.41 M)
(51.87 M)
(70.81 M)
(24.99 M)
8.35 K
(9.22 M)
(7.19 M)
(12.2 M)
(44.54 M)
(53.86 M)
Earnings Per Share
-0.28
-1.62
-0.66
-1.27
-1.02
-6.0
-1.27
-3.68
56.32
-52.8
Shares Owned By Insiders
46.77
8.5
0.63
0.51
2.84
3.99
16.8
7.37
62.55
N/A
Revenue
N/A
N/A
178.03 M
3.95 M
11.2 M
28.94 M
N/A
N/A
582 K
198 K
Working Capital
(6.26 M)
18.7 M
123.64 M
4.83 M
20.81 M
11.7 M
10.43 M
1.31 M
(586 K)
2.87 M
Cash And Equivalents
N/A
541 K
199.67 M
30.9 M
37.4 M
43.15 M
12.81 M
N/A
19.41 M
N/A
Cash Per Share
N/A
-0.79
1.22
1.25
0.42
0.9
0.83
N/A
6.6
N/A
Gross Profit
(208.83 K)
1.94 M
(63.61 M)
(19.38 M)
4.32 M
10.23 M
311.2 K
N/A
1 K
198 K
Day Typical Price
0.61
1.51
0.0377
0.19
4.48
2.95
1.42
2.44
1.25
17.78
Accumulation Distribution
0.0952
0.12
0.17
0.27
0.11
0.0467
0.0738
0.0442
0.0469
0.1
Market Facilitation Index
0.06
0.2
0.007
0.06
0.49
0.14
0.11
0.11
0.06
1.9
Daily Balance Of Power
(0.50)
(0.05)
(0.36)
0.3333
0.7143
0.8571
(0.64)
(0.36)
(0.67)
(0.66)
Period Momentum Indicator
(0.03)
(0.01)
(0)
0.02
0.35
0.12
(0.07)
(0.04)
(0.04)
(1.26)
Rate Of Daily Change
0.95
0.99
0.94
1.12
1.08
1.04
0.95
0.98
0.97
0.93
Day Median Price
0.6
1.51
0.0385
0.19
4.42
2.93
1.44
2.44
1.25
18.05
Price Action Indicator
0.005
0.005
(0)
0.01
0.37
0.13
(0.08)
(0.01)
(0.03)
(1.45)
Coefficient Of Variation
2845.65
(10,619)
(1,435)
(475.25)
487.82
(1,095)
(561.69)
(12,986)
1859.69
2022.53
Mean Deviation
6.9
4.17
12.67
5.09
3.17
2.82
3.17
4.6
4.77
7.89
Jensen Alpha
0.2133
(0.13)
(1.39)
(1.76)
0.9713
(0.39)
(0.88)
(0.02)
0.2913
0.7799
Total Risk Alpha
(0.44)
(0.59)
(3.13)
(2.23)
0.5468
(0.61)
(1.25)
(0.56)
(0.22)
(0.44)
Sortino Ratio
0.0346
N/A
N/A
N/A
0.2839
N/A
N/A
N/A
0.067
0.0476
Downside Variance
49.91
N/A
N/A
N/A
9.35
N/A
N/A
N/A
23.41
142.01
Standard Deviation
8.9
6.3
20.43
7.57
4.57
3.42
4.75
6.08
7.3
12.85
Kurtosis
0.9001
3.75
5.27
5.26
3.0
(0.67)
4.19
2.16
14.31
9.12
Potential Upside
16.67
9.09
49.18
8.11
12.67
5.21
5.2
8.89
13.33
17.5
Treynor Ratio
0.1975
(0.07)
1.87
(0.59)
(1.21)
(0.30)
(1.74)
0.0939
0.245
(0.24)
Maximum Drawdown
43.23
31.06
120.5
48.23
18.81
13.04
30.37
35.56
51.97
96.36
Variance
79.19
39.74
417.5
57.36
20.88
11.73
22.58
36.94
53.23
165.03
Market Risk Adjusted Performance
0.2075
(0.06)
1.88
(0.58)
(1.20)
(0.29)
(1.73)
0.1039
0.255
(0.23)
Risk Adjusted Performance
0.0339
0.0023
(0.04)
(0.14)
0.1523
(0.06)
(0.12)
0.0034
0.0468
0.0441
Skewness
0.9193
0.8455
(0.27)
(1.48)
1.59
0.1401
(0.65)
0.7583
2.94
1.75
Semi Deviation
6.66
N/A
N/A
N/A
2.26
N/A
N/A
N/A
4.65
9.08
Information Ratio
0.0275
(0.02)
(0.07)
(0.22)
0.19
(0.11)
(0.19)
(0.02)
0.0444
0.0441
Value At Risk
(10.34)
(8.48)
(18.18)
(13.16)
(4.48)
(5.31)
(6.91)
(9.64)
(7.41)
(17.72)
Expected Short fall
(9.14)
N/A
N/A
N/A
(3.88)
N/A
N/A
N/A
(5.66)
(11.41)
Downside Deviation
7.06
N/A
N/A
N/A
3.06
N/A
N/A
N/A
4.84
11.92
Semi Variance
44.34
N/A
N/A
N/A
5.09
N/A
N/A
N/A
21.63
82.48

OSR Holdings Competition Performance Charts

Five steps to successful analysis of OSR Holdings Competition

OSR Holdings' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by OSR Holdings in relation to its competition. OSR Holdings' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of OSR Holdings in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact OSR Holdings' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to OSR Holdings, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your OSR Holdings position

In addition to having OSR Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Silver Thematic Idea Now

Silver
Silver Theme
Companies involved in mining, production, and distribution of silver and silver goods. The Silver theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Silver Theme or any other thematic opportunities.
View All  Next Launch
When determining whether OSR Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OSR Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Osr Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Osr Holdings Stock:
How To Invest In OSR
Details
Is OSR Stock a good investment?
Details
What is OSR Holdings' Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out OSR Holdings Correlation with its peers.
For more detail on how to invest in OSR Stock please use our How to Invest in OSR Holdings guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OSR Holdings. If investors know OSR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OSR Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of OSR Holdings is measured differently than its book value, which is the value of OSR that is recorded on the company's balance sheet. Investors also form their own opinion of OSR Holdings' value that differs from its market value or its book value, called intrinsic value, which is OSR Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OSR Holdings' market value can be influenced by many factors that don't directly affect OSR Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between OSR Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OSR Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OSR Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY